Smith-Weller T - Search Results

1

Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism.

Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. Costa-Mallen P, et al. J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):535-7. doi: 10.1136/jnnp.69.4.535. J Neurol Neurosurg Psychiatry. 2000. PMID: 10990520 Free PMC article.

2

Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease.

Kelada SN, Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Checkoway H. Kelada SN, et al. Neurotoxicology. 2002 Oct;23(4-5):515-9. doi: 10.1016/s0161-813x(02)00061-x. Neurotoxicology. 2002. PMID: 12428723 Clinical Trial.

3

Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease.

Kushleika J, Checkoway H, Woods JS, Moon JD, Smith-Weller T, Franklin GM, Swanson PD. Kushleika J, et al. Ann Neurol. 1996 Mar;39(3):378-81. doi: 10.1002/ana.410390315. Ann Neurol. 1996. PMID: 8602757

4

Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease.

Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. Costa P, et al. Am J Med Genet. 1997 Apr 18;74(2):154-6. doi: 10.1002/(sici)1096-8628(19970418)74:2<154::aid-ajmg7>3.3.co;2-a. Am J Med Genet. 1997. PMID: 9129714

5

A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease.

Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD, Costa LG. Checkoway H, et al. Neurology. 1998 May;50(5):1458-61. doi: 10.1212/wnl.50.5.1458. Neurology. 1998. PMID: 9596006

6

The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease.

Costa-Mallen P, Checkoway H, Fishel M, Cohen AW, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. Costa-Mallen P, et al. Neurosci Lett. 2000 Jan 7;278(1-2):33-6. doi: 10.1016/s0304-3940(99)00890-3. Neurosci Lett. 2000. PMID: 10643794

7

Genetic polymorphisms of superoxide dismutase in Parkinson's disease.

Farin FM, Hitosis Y, Hallagan SE, Kushleika J, Woods JS, Janssen PS, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. Farin FM, et al. Mov Disord. 2001 Jul;16(4):705-7. doi: 10.1002/mds.1153. Mov Disord. 2001. PMID: 11481695

8

Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease.

Farin FM, Janssen P, Quigley S, Abbott D, Hassett C, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Omiecinski CJ, Checkoway H. Farin FM, et al. Pharmacogenetics. 2001 Nov;11(8):703-8. doi: 10.1097/00008571-200111000-00009. Pharmacogenetics. 2001. PMID: 11692079

9

Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease.

Kelada SN, Costa-Mallen P, Checkoway H, Viernes HA, Farin FM, Smith-Weller T, Franklin GM, Costa LG, Longstreth WT Jr, Furlong CE, Jarvik GP, Swanson PD. Kelada SN, et al. J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):546-7. doi: 10.1136/jnnp.74.4.546. J Neurol Neurosurg Psychiatry. 2003. PMID: 12640090 Free PMC article. No abstract available.

10

Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes.

Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H. Powers KM, et al. Neurology. 2003 Jun 10;60(11):1761-6. doi: 10.1212/01.wnl.0000068021.13945.7f. Neurology. 2003. PMID: 12796527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters